nodes	percent_of_prediction	percent_of_DWPC	metapath
Aprepitant—Cytochrome P450 3A4 Inhibitors—Ticagrelor—coronary artery disease	0.415	1	CiPCiCtD
Aprepitant—CYP2C19—coronary artery disease	0.102	1	CbGaD
Aprepitant—CYP3A7-CYP3A51P—Eplerenone—coronary artery disease	0.0121	0.0402	CbGbCtD
Aprepitant—CYP3A7—Eplerenone—coronary artery disease	0.0121	0.0402	CbGbCtD
Aprepitant—CYP3A5—Clopidogrel—coronary artery disease	0.0098	0.0324	CbGbCtD
Aprepitant—CYP2C9—Fenofibrate—coronary artery disease	0.00948	0.0314	CbGbCtD
Aprepitant—CYP2C19—Gemfibrozil—coronary artery disease	0.00911	0.0302	CbGbCtD
Aprepitant—CYP3A5—Eplerenone—coronary artery disease	0.00911	0.0302	CbGbCtD
Aprepitant—CYP1A2—Gemfibrozil—coronary artery disease	0.00841	0.0279	CbGbCtD
Aprepitant—CYP2C19—Clopidogrel—coronary artery disease	0.0079	0.0262	CbGbCtD
Aprepitant—CYP3A7—Simvastatin—coronary artery disease	0.00782	0.0259	CbGbCtD
Aprepitant—CYP3A7-CYP3A51P—Simvastatin—coronary artery disease	0.00782	0.0259	CbGbCtD
Aprepitant—CYP3A7-CYP3A51P—Lovastatin—coronary artery disease	0.00766	0.0254	CbGbCtD
Aprepitant—CYP3A7—Lovastatin—coronary artery disease	0.00766	0.0254	CbGbCtD
Aprepitant—CYP2C9—Gemfibrozil—coronary artery disease	0.00758	0.0251	CbGbCtD
Aprepitant—CYP1A2—Clopidogrel—coronary artery disease	0.00729	0.0241	CbGbCtD
Aprepitant—CYP3A7—Atorvastatin—coronary artery disease	0.00697	0.0231	CbGbCtD
Aprepitant—CYP3A7-CYP3A51P—Atorvastatin—coronary artery disease	0.00697	0.0231	CbGbCtD
Aprepitant—CYP2C19—Telmisartan—coronary artery disease	0.00691	0.0229	CbGbCtD
Aprepitant—CYP2C9—Clopidogrel—coronary artery disease	0.00657	0.0218	CbGbCtD
Aprepitant—CYP3A5—Rosuvastatin—coronary artery disease	0.00631	0.0209	CbGbCtD
Aprepitant—CYP3A4—Ticagrelor—coronary artery disease	0.00618	0.0205	CbGbCtD
Aprepitant—CYP3A5—Simvastatin—coronary artery disease	0.00587	0.0194	CbGbCtD
Aprepitant—CYP3A5—Pravastatin—coronary artery disease	0.00574	0.019	CbGbCtD
Aprepitant—CYP3A5—Lovastatin—coronary artery disease	0.00574	0.019	CbGbCtD
Aprepitant—CYP2C9—Pitavastatin—coronary artery disease	0.00574	0.019	CbGbCtD
Aprepitant—CYP2C9—Valsartan—coronary artery disease	0.00559	0.0185	CbGbCtD
Aprepitant—CYP2C19—Timolol—coronary artery disease	0.00557	0.0184	CbGbCtD
Aprepitant—CYP3A4—Fenofibrate—coronary artery disease	0.00551	0.0183	CbGbCtD
Aprepitant—CYP3A5—Atorvastatin—coronary artery disease	0.00523	0.0173	CbGbCtD
Aprepitant—CYP2C19—Rosuvastatin—coronary artery disease	0.00509	0.0169	CbGbCtD
Aprepitant—CYP2C19—Acetylsalicylic acid—coronary artery disease	0.00496	0.0164	CbGbCtD
Aprepitant—CYP3A5—Losartan—coronary artery disease	0.00478	0.0158	CbGbCtD
Aprepitant—CYP2C19—Simvastatin—coronary artery disease	0.00473	0.0157	CbGbCtD
Aprepitant—CYP2C19—Lovastatin—coronary artery disease	0.00463	0.0153	CbGbCtD
Aprepitant—CYP3A4—Gemfibrozil—coronary artery disease	0.00441	0.0146	CbGbCtD
Aprepitant—CYP2C9—Rosuvastatin—coronary artery disease	0.00423	0.014	CbGbCtD
Aprepitant—CYP2C19—Atorvastatin—coronary artery disease	0.00422	0.014	CbGbCtD
Aprepitant—CYP2C9—Acetylsalicylic acid—coronary artery disease	0.00413	0.0137	CbGbCtD
Aprepitant—CYP2C9—Simvastatin—coronary artery disease	0.00394	0.013	CbGbCtD
Aprepitant—CYP2C19—Losartan—coronary artery disease	0.00386	0.0128	CbGbCtD
Aprepitant—CYP2C9—Pravastatin—coronary artery disease	0.00385	0.0128	CbGbCtD
Aprepitant—CYP2C9—Lovastatin—coronary artery disease	0.00385	0.0128	CbGbCtD
Aprepitant—CYP3A4—Clopidogrel—coronary artery disease	0.00382	0.0127	CbGbCtD
Aprepitant—TACR1—vagus nerve—coronary artery disease	0.00379	0.402	CbGeAlD
Aprepitant—CYP1A2—Losartan—coronary artery disease	0.00356	0.0118	CbGbCtD
Aprepitant—CYP3A4—Eplerenone—coronary artery disease	0.00355	0.0118	CbGbCtD
Aprepitant—CYP2C9—Atorvastatin—coronary artery disease	0.00351	0.0116	CbGbCtD
Aprepitant—CYP2C9—Losartan—coronary artery disease	0.00321	0.0106	CbGbCtD
Aprepitant—CYP3A4—Enalapril—coronary artery disease	0.00316	0.0105	CbGbCtD
Aprepitant—CYP2C9—cardial valve—coronary artery disease	0.00294	0.312	CbGeAlD
Aprepitant—CYP3A4—Ezetimibe—coronary artery disease	0.00246	0.00815	CbGbCtD
Aprepitant—CYP3A4—Rosuvastatin—coronary artery disease	0.00246	0.00815	CbGbCtD
Aprepitant—CYP3A4—Simvastatin—coronary artery disease	0.00229	0.00758	CbGbCtD
Aprepitant—CYP3A4—Pravastatin—coronary artery disease	0.00224	0.00742	CbGbCtD
Aprepitant—CYP3A4—Lovastatin—coronary artery disease	0.00224	0.00742	CbGbCtD
Aprepitant—CYP3A4—Atorvastatin—coronary artery disease	0.00204	0.00676	CbGbCtD
Aprepitant—CYP3A4—Losartan—coronary artery disease	0.00187	0.00618	CbGbCtD
Aprepitant—TACR3—cardiovascular system—coronary artery disease	0.00134	0.142	CbGeAlD
Aprepitant—TACR1—blood—coronary artery disease	0.00041	0.0435	CbGeAlD
Aprepitant—CYP2C9—heart—coronary artery disease	0.000163	0.0173	CbGeAlD
Aprepitant—CYP2C19—blood—coronary artery disease	0.000156	0.0166	CbGeAlD
Aprepitant—CYP2C9—cardiovascular system—coronary artery disease	0.000153	0.0163	CbGeAlD
Aprepitant—CYP1A2—blood—coronary artery disease	0.000128	0.0136	CbGeAlD
Aprepitant—CYP3A5—blood—coronary artery disease	0.000123	0.0131	CbGeAlD
Aprepitant—CYP2C9—blood—coronary artery disease	0.000121	0.0129	CbGeAlD
Aprepitant—CYP3A4—blood—coronary artery disease	9.25e-05	0.00983	CbGeAlD
Aprepitant—Fatigue—Losartan—coronary artery disease	2.61e-05	0.000237	CcSEcCtD
Aprepitant—Headache—Ezetimibe—coronary artery disease	2.61e-05	0.000236	CcSEcCtD
Aprepitant—Malaise—Lisinopril—coronary artery disease	2.6e-05	0.000236	CcSEcCtD
Aprepitant—Oedema—Ramipril—coronary artery disease	2.6e-05	0.000235	CcSEcCtD
Aprepitant—Anaphylactic shock—Ramipril—coronary artery disease	2.6e-05	0.000235	CcSEcCtD
Aprepitant—Dry mouth—Timolol—coronary artery disease	2.59e-05	0.000235	CcSEcCtD
Aprepitant—Pain—Losartan—coronary artery disease	2.59e-05	0.000235	CcSEcCtD
Aprepitant—Constipation—Losartan—coronary artery disease	2.59e-05	0.000235	CcSEcCtD
Aprepitant—Syncope—Lisinopril—coronary artery disease	2.59e-05	0.000234	CcSEcCtD
Aprepitant—Vomiting—Eplerenone—coronary artery disease	2.59e-05	0.000234	CcSEcCtD
Aprepitant—Feeling abnormal—Furosemide—coronary artery disease	2.59e-05	0.000234	CcSEcCtD
Aprepitant—Nausea—Fenofibrate—coronary artery disease	2.58e-05	0.000234	CcSEcCtD
Aprepitant—Pruritus—Niacin—coronary artery disease	2.58e-05	0.000233	CcSEcCtD
Aprepitant—Asthenia—Pravastatin—coronary artery disease	2.57e-05	0.000233	CcSEcCtD
Aprepitant—Gastrointestinal pain—Furosemide—coronary artery disease	2.57e-05	0.000233	CcSEcCtD
Aprepitant—Rash—Eplerenone—coronary artery disease	2.57e-05	0.000232	CcSEcCtD
Aprepitant—Urticaria—Perindopril—coronary artery disease	2.57e-05	0.000232	CcSEcCtD
Aprepitant—Hypersensitivity—Trandolapril—coronary artery disease	2.57e-05	0.000232	CcSEcCtD
Aprepitant—Dermatitis—Eplerenone—coronary artery disease	2.56e-05	0.000232	CcSEcCtD
Aprepitant—Diarrhoea—Valsartan—coronary artery disease	2.56e-05	0.000232	CcSEcCtD
Aprepitant—Confusional state—Timolol—coronary artery disease	2.56e-05	0.000232	CcSEcCtD
Aprepitant—Shock—Ramipril—coronary artery disease	2.56e-05	0.000231	CcSEcCtD
Aprepitant—Hypersensitivity—Enalapril—coronary artery disease	2.56e-05	0.000231	CcSEcCtD
Aprepitant—Abdominal pain—Perindopril—coronary artery disease	2.55e-05	0.000231	CcSEcCtD
Aprepitant—Body temperature increased—Perindopril—coronary artery disease	2.55e-05	0.000231	CcSEcCtD
Aprepitant—Palpitations—Lisinopril—coronary artery disease	2.55e-05	0.000231	CcSEcCtD
Aprepitant—Diarrhoea—Olmesartan—coronary artery disease	2.55e-05	0.000231	CcSEcCtD
Aprepitant—Headache—Eplerenone—coronary artery disease	2.55e-05	0.000231	CcSEcCtD
Aprepitant—Nervous system disorder—Ramipril—coronary artery disease	2.55e-05	0.000231	CcSEcCtD
Aprepitant—Thrombocytopenia—Ramipril—coronary artery disease	2.54e-05	0.00023	CcSEcCtD
Aprepitant—Anaphylactic shock—Timolol—coronary artery disease	2.54e-05	0.00023	CcSEcCtD
Aprepitant—Oedema—Timolol—coronary artery disease	2.54e-05	0.00023	CcSEcCtD
Aprepitant—Pruritus—Pravastatin—coronary artery disease	2.54e-05	0.00023	CcSEcCtD
Aprepitant—Loss of consciousness—Lisinopril—coronary artery disease	2.54e-05	0.00023	CcSEcCtD
Aprepitant—Nausea—Clopidogrel—coronary artery disease	2.54e-05	0.00023	CcSEcCtD
Aprepitant—Tachycardia—Ramipril—coronary artery disease	2.53e-05	0.00023	CcSEcCtD
Aprepitant—Skin disorder—Ramipril—coronary artery disease	2.52e-05	0.000228	CcSEcCtD
Aprepitant—Infection—Timolol—coronary artery disease	2.52e-05	0.000228	CcSEcCtD
Aprepitant—Vomiting—Simvastatin—coronary artery disease	2.52e-05	0.000228	CcSEcCtD
Aprepitant—Hypersensitivity—Telmisartan—coronary artery disease	2.52e-05	0.000228	CcSEcCtD
Aprepitant—Cough—Lisinopril—coronary artery disease	2.52e-05	0.000228	CcSEcCtD
Aprepitant—Nausea—Lovastatin—coronary artery disease	2.52e-05	0.000228	CcSEcCtD
Aprepitant—Hyperhidrosis—Ramipril—coronary artery disease	2.51e-05	0.000227	CcSEcCtD
Aprepitant—Rash—Simvastatin—coronary artery disease	2.5e-05	0.000226	CcSEcCtD
Aprepitant—Dermatitis—Simvastatin—coronary artery disease	2.5e-05	0.000226	CcSEcCtD
Aprepitant—Asthenia—Trandolapril—coronary artery disease	2.5e-05	0.000226	CcSEcCtD
Aprepitant—Shock—Timolol—coronary artery disease	2.5e-05	0.000226	CcSEcCtD
Aprepitant—Feeling abnormal—Losartan—coronary artery disease	2.5e-05	0.000226	CcSEcCtD
Aprepitant—Urticaria—Furosemide—coronary artery disease	2.49e-05	0.000226	CcSEcCtD
Aprepitant—Diarrhoea—Niacin—coronary artery disease	2.49e-05	0.000226	CcSEcCtD
Aprepitant—Nervous system disorder—Timolol—coronary artery disease	2.49e-05	0.000226	CcSEcCtD
Aprepitant—Asthenia—Enalapril—coronary artery disease	2.49e-05	0.000225	CcSEcCtD
Aprepitant—Headache—Simvastatin—coronary artery disease	2.48e-05	0.000225	CcSEcCtD
Aprepitant—Body temperature increased—Furosemide—coronary artery disease	2.48e-05	0.000225	CcSEcCtD
Aprepitant—Abdominal pain—Furosemide—coronary artery disease	2.48e-05	0.000225	CcSEcCtD
Aprepitant—Gastrointestinal pain—Losartan—coronary artery disease	2.48e-05	0.000224	CcSEcCtD
Aprepitant—Dizziness—Valsartan—coronary artery disease	2.48e-05	0.000224	CcSEcCtD
Aprepitant—Anorexia—Ramipril—coronary artery disease	2.48e-05	0.000224	CcSEcCtD
Aprepitant—Nausea—Ezetimibe—coronary artery disease	2.47e-05	0.000224	CcSEcCtD
Aprepitant—Skin disorder—Timolol—coronary artery disease	2.47e-05	0.000223	CcSEcCtD
Aprepitant—Dizziness—Olmesartan—coronary artery disease	2.46e-05	0.000223	CcSEcCtD
Aprepitant—Pruritus—Trandolapril—coronary artery disease	2.46e-05	0.000223	CcSEcCtD
Aprepitant—Arthralgia—Lisinopril—coronary artery disease	2.46e-05	0.000223	CcSEcCtD
Aprepitant—Chest pain—Lisinopril—coronary artery disease	2.46e-05	0.000223	CcSEcCtD
Aprepitant—Myalgia—Lisinopril—coronary artery disease	2.46e-05	0.000223	CcSEcCtD
Aprepitant—Hyperhidrosis—Timolol—coronary artery disease	2.45e-05	0.000222	CcSEcCtD
Aprepitant—Asthenia—Telmisartan—coronary artery disease	2.45e-05	0.000222	CcSEcCtD
Aprepitant—Pruritus—Enalapril—coronary artery disease	2.45e-05	0.000222	CcSEcCtD
Aprepitant—Diarrhoea—Pravastatin—coronary artery disease	2.45e-05	0.000222	CcSEcCtD
Aprepitant—Anxiety—Lisinopril—coronary artery disease	2.45e-05	0.000222	CcSEcCtD
Aprepitant—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	2.44e-05	0.000221	CcSEcCtD
Aprepitant—Discomfort—Lisinopril—coronary artery disease	2.43e-05	0.00022	CcSEcCtD
Aprepitant—Hypotension—Ramipril—coronary artery disease	2.43e-05	0.00022	CcSEcCtD
Aprepitant—Anorexia—Timolol—coronary artery disease	2.42e-05	0.000219	CcSEcCtD
Aprepitant—Pruritus—Telmisartan—coronary artery disease	2.42e-05	0.000219	CcSEcCtD
Aprepitant—Nausea—Eplerenone—coronary artery disease	2.42e-05	0.000219	CcSEcCtD
Aprepitant—Dizziness—Niacin—coronary artery disease	2.41e-05	0.000218	CcSEcCtD
Aprepitant—Urticaria—Losartan—coronary artery disease	2.41e-05	0.000218	CcSEcCtD
Aprepitant—Dry mouth—Lisinopril—coronary artery disease	2.4e-05	0.000218	CcSEcCtD
Aprepitant—Body temperature increased—Losartan—coronary artery disease	2.39e-05	0.000217	CcSEcCtD
Aprepitant—Abdominal pain—Losartan—coronary artery disease	2.39e-05	0.000217	CcSEcCtD
Aprepitant—Asthenia—Captopril—coronary artery disease	2.39e-05	0.000216	CcSEcCtD
Aprepitant—Diarrhoea—Trandolapril—coronary artery disease	2.38e-05	0.000216	CcSEcCtD
Aprepitant—Vomiting—Valsartan—coronary artery disease	2.38e-05	0.000216	CcSEcCtD
Aprepitant—Confusional state—Lisinopril—coronary artery disease	2.38e-05	0.000215	CcSEcCtD
Aprepitant—Diarrhoea—Enalapril—coronary artery disease	2.37e-05	0.000215	CcSEcCtD
Aprepitant—Hypotension—Timolol—coronary artery disease	2.37e-05	0.000215	CcSEcCtD
Aprepitant—Dizziness—Pravastatin—coronary artery disease	2.37e-05	0.000215	CcSEcCtD
Aprepitant—Vomiting—Olmesartan—coronary artery disease	2.37e-05	0.000215	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Ramipril—coronary artery disease	2.37e-05	0.000214	CcSEcCtD
Aprepitant—Rash—Valsartan—coronary artery disease	2.36e-05	0.000214	CcSEcCtD
Aprepitant—Dermatitis—Valsartan—coronary artery disease	2.36e-05	0.000214	CcSEcCtD
Aprepitant—Nausea—Simvastatin—coronary artery disease	2.36e-05	0.000213	CcSEcCtD
Aprepitant—Oedema—Lisinopril—coronary artery disease	2.36e-05	0.000213	CcSEcCtD
Aprepitant—Anaphylactic shock—Lisinopril—coronary artery disease	2.36e-05	0.000213	CcSEcCtD
Aprepitant—Pruritus—Captopril—coronary artery disease	2.35e-05	0.000213	CcSEcCtD
Aprepitant—Rash—Olmesartan—coronary artery disease	2.35e-05	0.000213	CcSEcCtD
Aprepitant—Insomnia—Ramipril—coronary artery disease	2.35e-05	0.000213	CcSEcCtD
Aprepitant—Dermatitis—Olmesartan—coronary artery disease	2.35e-05	0.000213	CcSEcCtD
Aprepitant—Headache—Valsartan—coronary artery disease	2.35e-05	0.000213	CcSEcCtD
Aprepitant—Diarrhoea—Telmisartan—coronary artery disease	2.34e-05	0.000212	CcSEcCtD
Aprepitant—Infection—Lisinopril—coronary artery disease	2.34e-05	0.000212	CcSEcCtD
Aprepitant—Headache—Olmesartan—coronary artery disease	2.34e-05	0.000211	CcSEcCtD
Aprepitant—Paraesthesia—Ramipril—coronary artery disease	2.33e-05	0.000211	CcSEcCtD
Aprepitant—Shock—Lisinopril—coronary artery disease	2.32e-05	0.00021	CcSEcCtD
Aprepitant—Asthenia—Perindopril—coronary artery disease	2.32e-05	0.00021	CcSEcCtD
Aprepitant—Dyspnoea—Ramipril—coronary artery disease	2.32e-05	0.00021	CcSEcCtD
Aprepitant—Vomiting—Niacin—coronary artery disease	2.32e-05	0.00021	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Timolol—coronary artery disease	2.31e-05	0.00021	CcSEcCtD
Aprepitant—Hypersensitivity—Furosemide—coronary artery disease	2.31e-05	0.000209	CcSEcCtD
Aprepitant—Somnolence—Ramipril—coronary artery disease	2.31e-05	0.000209	CcSEcCtD
Aprepitant—Thrombocytopenia—Lisinopril—coronary artery disease	2.31e-05	0.000209	CcSEcCtD
Aprepitant—Dizziness—Trandolapril—coronary artery disease	2.3e-05	0.000209	CcSEcCtD
Aprepitant—Tachycardia—Lisinopril—coronary artery disease	2.3e-05	0.000208	CcSEcCtD
Aprepitant—Insomnia—Timolol—coronary artery disease	2.3e-05	0.000208	CcSEcCtD
Aprepitant—Rash—Niacin—coronary artery disease	2.3e-05	0.000208	CcSEcCtD
Aprepitant—Dermatitis—Niacin—coronary artery disease	2.29e-05	0.000208	CcSEcCtD
Aprepitant—Dizziness—Enalapril—coronary artery disease	2.29e-05	0.000208	CcSEcCtD
Aprepitant—Skin disorder—Lisinopril—coronary artery disease	2.29e-05	0.000207	CcSEcCtD
Aprepitant—Dyspepsia—Ramipril—coronary artery disease	2.29e-05	0.000207	CcSEcCtD
Aprepitant—Pruritus—Perindopril—coronary artery disease	2.28e-05	0.000207	CcSEcCtD
Aprepitant—Headache—Niacin—coronary artery disease	2.28e-05	0.000207	CcSEcCtD
Aprepitant—Paraesthesia—Timolol—coronary artery disease	2.28e-05	0.000207	CcSEcCtD
Aprepitant—Vomiting—Pravastatin—coronary artery disease	2.28e-05	0.000206	CcSEcCtD
Aprepitant—Hyperhidrosis—Lisinopril—coronary artery disease	2.28e-05	0.000206	CcSEcCtD
Aprepitant—Diarrhoea—Captopril—coronary artery disease	2.28e-05	0.000206	CcSEcCtD
Aprepitant—Dyspnoea—Timolol—coronary artery disease	2.26e-05	0.000205	CcSEcCtD
Aprepitant—Dizziness—Telmisartan—coronary artery disease	2.26e-05	0.000205	CcSEcCtD
Aprepitant—Rash—Pravastatin—coronary artery disease	2.26e-05	0.000205	CcSEcCtD
Aprepitant—Dermatitis—Pravastatin—coronary artery disease	2.26e-05	0.000205	CcSEcCtD
Aprepitant—Decreased appetite—Ramipril—coronary artery disease	2.26e-05	0.000204	CcSEcCtD
Aprepitant—Somnolence—Timolol—coronary artery disease	2.26e-05	0.000204	CcSEcCtD
Aprepitant—Asthenia—Furosemide—coronary artery disease	2.25e-05	0.000204	CcSEcCtD
Aprepitant—Headache—Pravastatin—coronary artery disease	2.25e-05	0.000203	CcSEcCtD
Aprepitant—Anorexia—Lisinopril—coronary artery disease	2.25e-05	0.000203	CcSEcCtD
Aprepitant—Gastrointestinal disorder—Ramipril—coronary artery disease	2.24e-05	0.000203	CcSEcCtD
Aprepitant—Fatigue—Ramipril—coronary artery disease	2.24e-05	0.000203	CcSEcCtD
Aprepitant—Dyspepsia—Timolol—coronary artery disease	2.24e-05	0.000202	CcSEcCtD
Aprepitant—Hypersensitivity—Losartan—coronary artery disease	2.23e-05	0.000202	CcSEcCtD
Aprepitant—Nausea—Valsartan—coronary artery disease	2.22e-05	0.000201	CcSEcCtD
Aprepitant—Pruritus—Furosemide—coronary artery disease	2.22e-05	0.000201	CcSEcCtD
Aprepitant—Constipation—Ramipril—coronary artery disease	2.22e-05	0.000201	CcSEcCtD
Aprepitant—Nausea—Olmesartan—coronary artery disease	2.21e-05	0.000201	CcSEcCtD
Aprepitant—Vomiting—Trandolapril—coronary artery disease	2.21e-05	0.000201	CcSEcCtD
Aprepitant—Diarrhoea—Perindopril—coronary artery disease	2.21e-05	0.0002	CcSEcCtD
Aprepitant—Decreased appetite—Timolol—coronary artery disease	2.21e-05	0.0002	CcSEcCtD
Aprepitant—Vomiting—Enalapril—coronary artery disease	2.2e-05	0.0002	CcSEcCtD
Aprepitant—Hypotension—Lisinopril—coronary artery disease	2.2e-05	0.000199	CcSEcCtD
Aprepitant—Dizziness—Captopril—coronary artery disease	2.2e-05	0.000199	CcSEcCtD
Aprepitant—Rash—Trandolapril—coronary artery disease	2.2e-05	0.000199	CcSEcCtD
Aprepitant—Dermatitis—Trandolapril—coronary artery disease	2.19e-05	0.000199	CcSEcCtD
Aprepitant—Gastrointestinal disorder—Timolol—coronary artery disease	2.19e-05	0.000199	CcSEcCtD
Aprepitant—Fatigue—Timolol—coronary artery disease	2.19e-05	0.000198	CcSEcCtD
Aprepitant—Rash—Enalapril—coronary artery disease	2.19e-05	0.000198	CcSEcCtD
Aprepitant—Dermatitis—Enalapril—coronary artery disease	2.18e-05	0.000198	CcSEcCtD
Aprepitant—Headache—Trandolapril—coronary artery disease	2.18e-05	0.000198	CcSEcCtD
Aprepitant—Vomiting—Telmisartan—coronary artery disease	2.17e-05	0.000197	CcSEcCtD
Aprepitant—Asthenia—Losartan—coronary artery disease	2.17e-05	0.000197	CcSEcCtD
Aprepitant—Headache—Enalapril—coronary artery disease	2.17e-05	0.000197	CcSEcCtD
Aprepitant—Pain—Timolol—coronary artery disease	2.17e-05	0.000197	CcSEcCtD
Aprepitant—Nausea—Niacin—coronary artery disease	2.16e-05	0.000196	CcSEcCtD
Aprepitant—Rash—Telmisartan—coronary artery disease	2.16e-05	0.000195	CcSEcCtD
Aprepitant—Dermatitis—Telmisartan—coronary artery disease	2.15e-05	0.000195	CcSEcCtD
Aprepitant—Diarrhoea—Furosemide—coronary artery disease	2.15e-05	0.000195	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Lisinopril—coronary artery disease	2.15e-05	0.000194	CcSEcCtD
Aprepitant—Pruritus—Losartan—coronary artery disease	2.14e-05	0.000194	CcSEcCtD
Aprepitant—Headache—Telmisartan—coronary artery disease	2.14e-05	0.000194	CcSEcCtD
Aprepitant—Feeling abnormal—Ramipril—coronary artery disease	2.14e-05	0.000194	CcSEcCtD
Aprepitant—Dizziness—Perindopril—coronary artery disease	2.14e-05	0.000193	CcSEcCtD
Aprepitant—Insomnia—Lisinopril—coronary artery disease	2.13e-05	0.000193	CcSEcCtD
Aprepitant—Nausea—Pravastatin—coronary artery disease	2.13e-05	0.000193	CcSEcCtD
Aprepitant—Gastrointestinal pain—Ramipril—coronary artery disease	2.12e-05	0.000192	CcSEcCtD
Aprepitant—Paraesthesia—Lisinopril—coronary artery disease	2.12e-05	0.000192	CcSEcCtD
Aprepitant—Vomiting—Captopril—coronary artery disease	2.11e-05	0.000192	CcSEcCtD
Aprepitant—Dyspnoea—Lisinopril—coronary artery disease	2.1e-05	0.00019	CcSEcCtD
Aprepitant—Rash—Captopril—coronary artery disease	2.1e-05	0.00019	CcSEcCtD
Aprepitant—Dermatitis—Captopril—coronary artery disease	2.1e-05	0.00019	CcSEcCtD
Aprepitant—Somnolence—Lisinopril—coronary artery disease	2.09e-05	0.00019	CcSEcCtD
Aprepitant—Feeling abnormal—Timolol—coronary artery disease	2.09e-05	0.00019	CcSEcCtD
Aprepitant—Headache—Captopril—coronary artery disease	2.08e-05	0.000189	CcSEcCtD
Aprepitant—Gastrointestinal pain—Timolol—coronary artery disease	2.08e-05	0.000188	CcSEcCtD
Aprepitant—Dizziness—Furosemide—coronary artery disease	2.08e-05	0.000188	CcSEcCtD
Aprepitant—Dyspepsia—Lisinopril—coronary artery disease	2.07e-05	0.000188	CcSEcCtD
Aprepitant—Diarrhoea—Losartan—coronary artery disease	2.07e-05	0.000188	CcSEcCtD
Aprepitant—Nausea—Trandolapril—coronary artery disease	2.07e-05	0.000187	CcSEcCtD
Aprepitant—Urticaria—Ramipril—coronary artery disease	2.06e-05	0.000187	CcSEcCtD
Aprepitant—Nausea—Enalapril—coronary artery disease	2.06e-05	0.000187	CcSEcCtD
Aprepitant—Vomiting—Perindopril—coronary artery disease	2.05e-05	0.000186	CcSEcCtD
Aprepitant—Body temperature increased—Ramipril—coronary artery disease	2.05e-05	0.000186	CcSEcCtD
Aprepitant—Abdominal pain—Ramipril—coronary artery disease	2.05e-05	0.000186	CcSEcCtD
Aprepitant—Decreased appetite—Lisinopril—coronary artery disease	2.05e-05	0.000185	CcSEcCtD
Aprepitant—Rash—Perindopril—coronary artery disease	2.04e-05	0.000184	CcSEcCtD
Aprepitant—Dermatitis—Perindopril—coronary artery disease	2.03e-05	0.000184	CcSEcCtD
Aprepitant—Gastrointestinal disorder—Lisinopril—coronary artery disease	2.03e-05	0.000184	CcSEcCtD
Aprepitant—Nausea—Telmisartan—coronary artery disease	2.03e-05	0.000184	CcSEcCtD
Aprepitant—Fatigue—Lisinopril—coronary artery disease	2.03e-05	0.000184	CcSEcCtD
Aprepitant—Headache—Perindopril—coronary artery disease	2.02e-05	0.000183	CcSEcCtD
Aprepitant—Urticaria—Timolol—coronary artery disease	2.02e-05	0.000183	CcSEcCtD
Aprepitant—Constipation—Lisinopril—coronary artery disease	2.01e-05	0.000182	CcSEcCtD
Aprepitant—Pain—Lisinopril—coronary artery disease	2.01e-05	0.000182	CcSEcCtD
Aprepitant—Abdominal pain—Timolol—coronary artery disease	2.01e-05	0.000182	CcSEcCtD
Aprepitant—Body temperature increased—Timolol—coronary artery disease	2.01e-05	0.000182	CcSEcCtD
Aprepitant—Dizziness—Losartan—coronary artery disease	2e-05	0.000181	CcSEcCtD
Aprepitant—Vomiting—Furosemide—coronary artery disease	2e-05	0.000181	CcSEcCtD
Aprepitant—Rash—Furosemide—coronary artery disease	1.98e-05	0.000179	CcSEcCtD
Aprepitant—Dermatitis—Furosemide—coronary artery disease	1.98e-05	0.000179	CcSEcCtD
Aprepitant—Nausea—Captopril—coronary artery disease	1.98e-05	0.000179	CcSEcCtD
Aprepitant—Headache—Furosemide—coronary artery disease	1.97e-05	0.000178	CcSEcCtD
Aprepitant—Feeling abnormal—Lisinopril—coronary artery disease	1.94e-05	0.000176	CcSEcCtD
Aprepitant—Gastrointestinal pain—Lisinopril—coronary artery disease	1.93e-05	0.000174	CcSEcCtD
Aprepitant—Vomiting—Losartan—coronary artery disease	1.93e-05	0.000174	CcSEcCtD
Aprepitant—Nausea—Perindopril—coronary artery disease	1.92e-05	0.000174	CcSEcCtD
Aprepitant—Hypersensitivity—Ramipril—coronary artery disease	1.91e-05	0.000173	CcSEcCtD
Aprepitant—Rash—Losartan—coronary artery disease	1.91e-05	0.000173	CcSEcCtD
Aprepitant—Dermatitis—Losartan—coronary artery disease	1.91e-05	0.000173	CcSEcCtD
Aprepitant—Headache—Losartan—coronary artery disease	1.9e-05	0.000172	CcSEcCtD
Aprepitant—Urticaria—Lisinopril—coronary artery disease	1.87e-05	0.000169	CcSEcCtD
Aprepitant—Hypersensitivity—Timolol—coronary artery disease	1.87e-05	0.000169	CcSEcCtD
Aprepitant—Nausea—Furosemide—coronary artery disease	1.86e-05	0.000169	CcSEcCtD
Aprepitant—Asthenia—Ramipril—coronary artery disease	1.86e-05	0.000169	CcSEcCtD
Aprepitant—Body temperature increased—Lisinopril—coronary artery disease	1.86e-05	0.000169	CcSEcCtD
Aprepitant—Abdominal pain—Lisinopril—coronary artery disease	1.86e-05	0.000169	CcSEcCtD
Aprepitant—Pruritus—Ramipril—coronary artery disease	1.84e-05	0.000166	CcSEcCtD
Aprepitant—Asthenia—Timolol—coronary artery disease	1.82e-05	0.000165	CcSEcCtD
Aprepitant—Nausea—Losartan—coronary artery disease	1.8e-05	0.000163	CcSEcCtD
Aprepitant—Pruritus—Timolol—coronary artery disease	1.8e-05	0.000163	CcSEcCtD
Aprepitant—Diarrhoea—Ramipril—coronary artery disease	1.78e-05	0.000161	CcSEcCtD
Aprepitant—Diarrhoea—Timolol—coronary artery disease	1.74e-05	0.000157	CcSEcCtD
Aprepitant—Hypersensitivity—Lisinopril—coronary artery disease	1.74e-05	0.000157	CcSEcCtD
Aprepitant—Dizziness—Ramipril—coronary artery disease	1.72e-05	0.000156	CcSEcCtD
Aprepitant—Asthenia—Lisinopril—coronary artery disease	1.69e-05	0.000153	CcSEcCtD
Aprepitant—Dizziness—Timolol—coronary artery disease	1.68e-05	0.000152	CcSEcCtD
Aprepitant—Pruritus—Lisinopril—coronary artery disease	1.67e-05	0.000151	CcSEcCtD
Aprepitant—Vomiting—Ramipril—coronary artery disease	1.65e-05	0.00015	CcSEcCtD
Aprepitant—Rash—Ramipril—coronary artery disease	1.64e-05	0.000148	CcSEcCtD
Aprepitant—Dermatitis—Ramipril—coronary artery disease	1.64e-05	0.000148	CcSEcCtD
Aprepitant—Headache—Ramipril—coronary artery disease	1.63e-05	0.000147	CcSEcCtD
Aprepitant—Vomiting—Timolol—coronary artery disease	1.61e-05	0.000146	CcSEcCtD
Aprepitant—Diarrhoea—Lisinopril—coronary artery disease	1.61e-05	0.000146	CcSEcCtD
Aprepitant—Rash—Timolol—coronary artery disease	1.6e-05	0.000145	CcSEcCtD
Aprepitant—Dermatitis—Timolol—coronary artery disease	1.6e-05	0.000145	CcSEcCtD
Aprepitant—Headache—Timolol—coronary artery disease	1.59e-05	0.000144	CcSEcCtD
Aprepitant—Dizziness—Lisinopril—coronary artery disease	1.56e-05	0.000141	CcSEcCtD
Aprepitant—Nausea—Ramipril—coronary artery disease	1.54e-05	0.00014	CcSEcCtD
Aprepitant—Nausea—Timolol—coronary artery disease	1.51e-05	0.000137	CcSEcCtD
Aprepitant—Vomiting—Lisinopril—coronary artery disease	1.5e-05	0.000136	CcSEcCtD
Aprepitant—Rash—Lisinopril—coronary artery disease	1.49e-05	0.000135	CcSEcCtD
Aprepitant—Dermatitis—Lisinopril—coronary artery disease	1.48e-05	0.000134	CcSEcCtD
Aprepitant—Headache—Lisinopril—coronary artery disease	1.48e-05	0.000134	CcSEcCtD
Aprepitant—Nausea—Lisinopril—coronary artery disease	1.4e-05	0.000127	CcSEcCtD
Aprepitant—CYP1A2—Metabolism—LPA—coronary artery disease	2.32e-06	3.8e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—GSTT1—coronary artery disease	2.31e-06	3.78e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—SLC9A1—coronary artery disease	2.31e-06	3.78e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—GGT1—coronary artery disease	2.31e-06	3.78e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—GOT1—coronary artery disease	2.31e-06	3.78e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—CETP—coronary artery disease	2.28e-06	3.74e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—GCLC—coronary artery disease	2.28e-06	3.74e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—DCN—coronary artery disease	2.28e-06	3.73e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—SLC27A1—coronary artery disease	2.27e-06	3.71e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—SDC1—coronary artery disease	2.26e-06	3.7e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PLCB3—coronary artery disease	2.25e-06	3.68e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—APOA5—coronary artery disease	2.23e-06	3.65e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—CPT1B—coronary artery disease	2.22e-06	3.64e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—LCAT—coronary artery disease	2.22e-06	3.64e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—ALDH2—coronary artery disease	2.21e-06	3.63e-05	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—AGT—coronary artery disease	2.21e-06	3.62e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—P4HB—coronary artery disease	2.18e-06	3.57e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—APOA4—coronary artery disease	2.18e-06	3.57e-05	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—APOE—coronary artery disease	2.17e-06	3.55e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—AGT—coronary artery disease	2.16e-06	3.54e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	2.16e-06	3.54e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—HBA1—coronary artery disease	2.16e-06	3.53e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—CYP2C19—coronary artery disease	2.16e-06	3.53e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—LIPC—coronary artery disease	2.16e-06	3.53e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PIK3C2A—coronary artery disease	2.16e-06	3.53e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—APOC3—coronary artery disease	2.14e-06	3.51e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PLA2G1B—coronary artery disease	2.14e-06	3.51e-05	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—APOA1—coronary artery disease	2.14e-06	3.51e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PSMA6—coronary artery disease	2.13e-06	3.49e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PSMB5—coronary artery disease	2.13e-06	3.49e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—LDLR—coronary artery disease	2.13e-06	3.49e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	2.13e-06	3.49e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	2.13e-06	3.49e-05	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—PIK3CA—coronary artery disease	2.13e-06	3.48e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—APOE—coronary artery disease	2.12e-06	3.47e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PDHA1—coronary artery disease	2.11e-06	3.45e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—GCLM—coronary artery disease	2.11e-06	3.45e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—GSTT1—coronary artery disease	2.11e-06	3.45e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—SLC9A1—coronary artery disease	2.11e-06	3.45e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—coronary artery disease	2.09e-06	3.43e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—CTGF—coronary artery disease	2.08e-06	3.41e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—GCLC—coronary artery disease	2.08e-06	3.41e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—CETP—coronary artery disease	2.08e-06	3.41e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—GSTP1—coronary artery disease	2.07e-06	3.39e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—HMGCR—coronary artery disease	2.06e-06	3.38e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—GOT2—coronary artery disease	2.06e-06	3.38e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—SDC1—coronary artery disease	2.06e-06	3.37e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—PPARGC1A—coronary artery disease	2.05e-06	3.36e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—HMOX1—coronary artery disease	2.04e-06	3.35e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—CYP11B2—coronary artery disease	2.04e-06	3.34e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—TXNRD1—coronary artery disease	2.04e-06	3.34e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—VCAN—coronary artery disease	2.02e-06	3.31e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—CAT—coronary artery disease	2.02e-06	3.3e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—SLC22A3—coronary artery disease	2.01e-06	3.29e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—ALDOA—coronary artery disease	2e-06	3.28e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—ARNTL—coronary artery disease	1.98e-06	3.24e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—HADH—coronary artery disease	1.98e-06	3.24e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—APOB—coronary artery disease	1.96e-06	3.2e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—DCN—coronary artery disease	1.94e-06	3.19e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PSMB5—coronary artery disease	1.94e-06	3.19e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PSMA6—coronary artery disease	1.94e-06	3.19e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	1.94e-06	3.18e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—GSTM1—coronary artery disease	1.9e-06	3.12e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—CTGF—coronary artery disease	1.9e-06	3.11e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PLCB1—coronary artery disease	1.9e-06	3.11e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—ALDH2—coronary artery disease	1.89e-06	3.1e-05	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—PPARG—coronary artery disease	1.89e-06	3.09e-05	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—IL6—coronary artery disease	1.88e-06	3.08e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—HMGCR—coronary artery disease	1.88e-06	3.08e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—GOT2—coronary artery disease	1.88e-06	3.08e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—APOA2—coronary artery disease	1.88e-06	3.08e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PLA2G2A—coronary artery disease	1.88e-06	3.08e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—GPX2—coronary artery disease	1.88e-06	3.08e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—LPL—coronary artery disease	1.87e-06	3.06e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	1.86e-06	3.05e-05	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—POMC—coronary artery disease	1.86e-06	3.05e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—GPX4—coronary artery disease	1.85e-06	3.04e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—ABCG5—coronary artery disease	1.85e-06	3.04e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—HK1—coronary artery disease	1.85e-06	3.04e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—SULT1A1—coronary artery disease	1.85e-06	3.04e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	1.84e-06	3.02e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—HBA1—coronary artery disease	1.84e-06	3.02e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—LIPC—coronary artery disease	1.84e-06	3.02e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—CYP2C19—coronary artery disease	1.84e-06	3.02e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PIK3C2A—coronary artery disease	1.84e-06	3.02e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—ABCA1—coronary artery disease	1.84e-06	3.01e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—HADHA—coronary artery disease	1.83e-06	3e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—APOC3—coronary artery disease	1.83e-06	3e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—GPX1—coronary artery disease	1.82e-06	2.99e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—LDLR—coronary artery disease	1.82e-06	2.98e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	1.82e-06	2.98e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—GSTA1—coronary artery disease	1.81e-06	2.97e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—SLC9A1—coronary artery disease	1.8e-06	2.95e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—GSTT1—coronary artery disease	1.8e-06	2.95e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—LPA—coronary artery disease	1.79e-06	2.93e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—GGT1—coronary artery disease	1.78e-06	2.92e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—GOT1—coronary artery disease	1.78e-06	2.92e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—GCLC—coronary artery disease	1.78e-06	2.91e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—CETP—coronary artery disease	1.78e-06	2.91e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—CD36—coronary artery disease	1.77e-06	2.91e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—SDC1—coronary artery disease	1.76e-06	2.88e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—PPP2CA—coronary artery disease	1.75e-06	2.87e-05	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—AKT1—coronary artery disease	1.74e-06	2.85e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PLCB3—coronary artery disease	1.73e-06	2.84e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PLCB1—coronary artery disease	1.73e-06	2.84e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—APOA5—coronary artery disease	1.72e-06	2.81e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	1.7e-06	2.78e-05	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—ALB—coronary artery disease	1.7e-06	2.78e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—P4HB—coronary artery disease	1.68e-06	2.76e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—MTHFR—coronary artery disease	1.68e-06	2.75e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—ABCA1—coronary artery disease	1.68e-06	2.75e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PSMA6—coronary artery disease	1.66e-06	2.72e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PSMB5—coronary artery disease	1.66e-06	2.72e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	1.66e-06	2.72e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	1.65e-06	2.71e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—GGT1—coronary artery disease	1.63e-06	2.66e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—GOT1—coronary artery disease	1.63e-06	2.66e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—CTGF—coronary artery disease	1.62e-06	2.66e-05	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—NOS3—coronary artery disease	1.62e-06	2.66e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—HMGCR—coronary artery disease	1.61e-06	2.64e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—GOT2—coronary artery disease	1.61e-06	2.64e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—GSTP1—coronary artery disease	1.6e-06	2.62e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—AGT—coronary artery disease	1.6e-06	2.62e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PPARGC1A—coronary artery disease	1.59e-06	2.6e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—HMOX1—coronary artery disease	1.58e-06	2.59e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—APOE—coronary artery disease	1.57e-06	2.56e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—VCAN—coronary artery disease	1.56e-06	2.55e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—CAT—coronary artery disease	1.56e-06	2.55e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—APOA1—coronary artery disease	1.55e-06	2.54e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—ALDOA—coronary artery disease	1.55e-06	2.53e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—APOB—coronary artery disease	1.51e-06	2.48e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—DCN—coronary artery disease	1.5e-06	2.46e-05	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—PTGS2—coronary artery disease	1.48e-06	2.43e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PLCB1—coronary artery disease	1.48e-06	2.42e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—GSTM1—coronary artery disease	1.47e-06	2.41e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—ALDH2—coronary artery disease	1.46e-06	2.39e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—GSTP1—coronary artery disease	1.46e-06	2.39e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	1.45e-06	2.38e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PPARGC1A—coronary artery disease	1.45e-06	2.37e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—LPL—coronary artery disease	1.44e-06	2.37e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—HMOX1—coronary artery disease	1.44e-06	2.36e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—ABCA1—coronary artery disease	1.43e-06	2.35e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—HBA1—coronary artery disease	1.42e-06	2.33e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—LIPC—coronary artery disease	1.42e-06	2.33e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—CYP2C19—coronary artery disease	1.42e-06	2.33e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	1.42e-06	2.33e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—CAT—coronary artery disease	1.42e-06	2.33e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—APOC3—coronary artery disease	1.41e-06	2.32e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—GPX1—coronary artery disease	1.41e-06	2.31e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—LDLR—coronary artery disease	1.41e-06	2.3e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—GSTT1—coronary artery disease	1.39e-06	2.28e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—SLC9A1—coronary artery disease	1.39e-06	2.28e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—GOT1—coronary artery disease	1.39e-06	2.27e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—GGT1—coronary artery disease	1.39e-06	2.27e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—APOB—coronary artery disease	1.38e-06	2.26e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—CETP—coronary artery disease	1.37e-06	2.25e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—GCLC—coronary artery disease	1.37e-06	2.25e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—CD36—coronary artery disease	1.37e-06	2.25e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—PPARG—coronary artery disease	1.36e-06	2.23e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—SDC1—coronary artery disease	1.36e-06	2.22e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PPP2CA—coronary artery disease	1.35e-06	2.22e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—POMC—coronary artery disease	1.34e-06	2.2e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—GSTM1—coronary artery disease	1.34e-06	2.2e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—LPL—coronary artery disease	1.32e-06	2.16e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—MTHFR—coronary artery disease	1.3e-06	2.13e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—GPX1—coronary artery disease	1.28e-06	2.1e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PSMA6—coronary artery disease	1.28e-06	2.1e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PSMB5—coronary artery disease	1.28e-06	2.1e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—CTGF—coronary artery disease	1.25e-06	2.05e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—CD36—coronary artery disease	1.25e-06	2.05e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—GSTP1—coronary artery disease	1.25e-06	2.04e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—GOT2—coronary artery disease	1.24e-06	2.03e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—HMGCR—coronary artery disease	1.24e-06	2.03e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PPARGC1A—coronary artery disease	1.24e-06	2.02e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PPP2CA—coronary artery disease	1.24e-06	2.02e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—AGT—coronary artery disease	1.24e-06	2.02e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—HMOX1—coronary artery disease	1.23e-06	2.02e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—ALB—coronary artery disease	1.23e-06	2.01e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—CAT—coronary artery disease	1.21e-06	1.99e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—APOE—coronary artery disease	1.21e-06	1.98e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—APOA1—coronary artery disease	1.2e-06	1.96e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—MTHFR—coronary artery disease	1.19e-06	1.94e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—APOB—coronary artery disease	1.18e-06	1.93e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—NOS3—coronary artery disease	1.17e-06	1.92e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—GSTM1—coronary artery disease	1.15e-06	1.88e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	1.15e-06	1.88e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PLCB1—coronary artery disease	1.14e-06	1.87e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—AGT—coronary artery disease	1.13e-06	1.85e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—LPL—coronary artery disease	1.13e-06	1.84e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—ABCA1—coronary artery disease	1.11e-06	1.81e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—APOE—coronary artery disease	1.1e-06	1.81e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—GPX1—coronary artery disease	1.1e-06	1.8e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—APOA1—coronary artery disease	1.09e-06	1.79e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—PTGS2—coronary artery disease	1.07e-06	1.76e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—GOT1—coronary artery disease	1.07e-06	1.76e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—GGT1—coronary artery disease	1.07e-06	1.76e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—CD36—coronary artery disease	1.07e-06	1.75e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PPP2CA—coronary artery disease	1.06e-06	1.73e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PPARG—coronary artery disease	1.05e-06	1.73e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	1.04e-06	1.71e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—POMC—coronary artery disease	1.04e-06	1.7e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—MTHFR—coronary artery disease	1.01e-06	1.66e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—GSTP1—coronary artery disease	9.63e-07	1.58e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—AGT—coronary artery disease	9.63e-07	1.58e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PPARG—coronary artery disease	9.61e-07	1.57e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	9.54e-07	1.56e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—HMOX1—coronary artery disease	9.49e-07	1.56e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—POMC—coronary artery disease	9.48e-07	1.55e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—ALB—coronary artery disease	9.48e-07	1.55e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—APOE—coronary artery disease	9.43e-07	1.54e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—CAT—coronary artery disease	9.37e-07	1.53e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—APOA1—coronary artery disease	9.32e-07	1.53e-05	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—PIK3CA—coronary artery disease	9.13e-07	1.5e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—APOB—coronary artery disease	9.09e-07	1.49e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—NOS3—coronary artery disease	9.07e-07	1.49e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	8.93e-07	1.46e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—GSTM1—coronary artery disease	8.85e-07	1.45e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—LPL—coronary artery disease	8.68e-07	1.42e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—ALB—coronary artery disease	8.64e-07	1.42e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—GPX1—coronary artery disease	8.47e-07	1.39e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PTGS2—coronary artery disease	8.29e-07	1.36e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—NOS3—coronary artery disease	8.27e-07	1.35e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—CD36—coronary artery disease	8.25e-07	1.35e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PPARG—coronary artery disease	8.22e-07	1.35e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PPP2CA—coronary artery disease	8.15e-07	1.33e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—POMC—coronary artery disease	8.1e-07	1.33e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—MTHFR—coronary artery disease	7.82e-07	1.28e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PTGS2—coronary artery disease	7.56e-07	1.24e-05	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—AKT1—coronary artery disease	7.46e-07	1.22e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—AGT—coronary artery disease	7.43e-07	1.22e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—ALB—coronary artery disease	7.39e-07	1.21e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—APOE—coronary artery disease	7.28e-07	1.19e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—APOA1—coronary artery disease	7.2e-07	1.18e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—NOS3—coronary artery disease	7.07e-07	1.16e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—PIK3CA—coronary artery disease	6.6e-07	1.08e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PTGS2—coronary artery disease	6.46e-07	1.06e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PPARG—coronary artery disease	6.34e-07	1.04e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—POMC—coronary artery disease	6.25e-07	1.02e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—ALB—coronary artery disease	5.7e-07	9.34e-06	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—NOS3—coronary artery disease	5.45e-07	8.93e-06	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—AKT1—coronary artery disease	5.39e-07	8.83e-06	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PIK3CA—coronary artery disease	5.1e-07	8.36e-06	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PTGS2—coronary artery disease	4.99e-07	8.17e-06	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PIK3CA—coronary artery disease	4.65e-07	7.62e-06	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—AKT1—coronary artery disease	4.17e-07	6.83e-06	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PIK3CA—coronary artery disease	3.98e-07	6.51e-06	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—AKT1—coronary artery disease	3.8e-07	6.23e-06	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—AKT1—coronary artery disease	3.25e-07	5.32e-06	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PIK3CA—coronary artery disease	3.07e-07	5.03e-06	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—AKT1—coronary artery disease	2.51e-07	4.11e-06	CbGpPWpGaD
